Characterisation of high and low avidity peptide specific CD8+ T cells using immunologic, transcriptomic and proteomic tools
Explore this paper's citation graph
Summary
A C57Bl/6J mouse model could efficiently generate high and low avidity T cell responses, when immunisation was undertaken with two form of vaccines to deliver the target antigens and showed the plasticity of antigen specific T cells and their ability to modulate their functionality according to the stimulation they have received.
- Published
- 2013-01-01
- Cited by
- 0
- References
- 580
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:81991032
References
- Expression Profiling Using Affymetrix GeneChip Microarrays.
- The proto‐oncogene Vav product is constitutively tyrosine‐phosphorylated in normal human immature T cells
- Changes in an HER‐2 Peptide Upregulating HLA‐A2 Expression Affect Both Conformational Epitopes and CTL Recognition: Implications for Optimization of Antigen Presentation and Tumor‐Specific CTL Induction
- The use of melanosomal proteins in the immunotherapy of melanoma.
- Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma
- Costimulation induced phosphorylation of L‐plastin facilitates surface transport of the T cell activation molecules CD69 and CD25
- CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
- The actin filament cross-linker L-plastin confers resistance to TNF-α in MCF-7 breast cancer cells in a phosphorylation-dependent manner
- LFA-1 contributes to signal I of T-cell activation and to the production of T(h)1 cytokines.
- Radiotherapy of prostate cancer.
- Therapeutic cancer vaccines: current status and moving forward.
- The interaction of HspA1A with TLR2 and TLR4 in the response of neutrophils induced by ovarian cancer cells in vitro
- Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection
- Role of the PD-1 Pathway in the Immune Response
- Postoperative complications following neoadjuvant bevacizumab treatment for advanced colorectal cancer
- Quantitation of Gene Expression in Formaldehyde-Fixed and Fluorescence-Activated Sorted Cells
- Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma.
- Relating alternative splicing to proteome complexity and genome evolution.
- Glycoprotein enrichment through lectin affinity techniques.
- Nano LC-MS/MS: a robust setup for proteomic analysis.
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.